Diagnostics and Tools

Outcomes

WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P.

Outcomes

Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners

Outcomes

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Outcomes

HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners

Outcomes

MolecularMD has been acquired by ICON Plc.

Outcomes

Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza

Outcomes

PhenoPath has been acquired by Quest Diagnostics September 2018

Outcomes

OmniSeq Received a Strategic Investment from HITACHI April 12, 2018

Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq.

Outcomes

MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018

Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics.

Outcomes

Trevigen acquired by Bio-Techne September 5, 2017

Crosstree Capital Partners acted as exclusive financial advisor to Trevigen.

Gain Insight

Your monthly coverage of M&A, recapitalization, and growth financing transactions worldwide. Stay apprised of valuations and related segment trends in your industry with Crosstree’s monthly BlueBooks.